Paper37190841
[Mechanism of miR-26a-5p/cAMP response element binding protein 1 molecular axis regulating osteogenic differentiation of adipose-derived mesenchymal stem cells].
Lin S and 5 others. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. [Mechanism of miR-26a-5p/cAMP response element binding protein 1 molecular axis regulating osteogenic differentiation of adipose-derived mesenchymal stem cells]. Papers, record 37190841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37190841
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Mechanism of miR-26a-5p/cAMP response element binding protein 1 molecular axis regulating osteogenic differentiation of adipose-derived mesenchymal stem cells].
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cells | Major topic |
| MicroRNAs | Major topic |
| Animals | |
| Female | |
| Mice | |
| Cell Differentiation | |
| Cells, Cultured | |
| Core Binding Factor Alpha 1 Subunit | |
| Cyclic AMP Response Element-Binding Protein | |
| Mice, Inbred C57BL | |
| Osteocalcin | |
| Osteogenesis | |
| RNA, Messenger | |
| Anthraquinones |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30572770 | Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus. | Lupus | 2019 | https://conductscience.org/library/papers/30572770 | PubMed |
| 2 | 34635983 | Long noncoding RNA XIST modulates microRNA-135/CREB1 axis to influence osteogenic differentiation of osteoblast-like cells in mice with tibial fracture healing. | Hum Cell | 2022 | https://conductscience.org/library/papers/34635983 | PubMed |
| 3 | 32273724 | miR-26a-5p Inhibit Gastric Cancer Cell Proliferation and Invasion Through Mediated Wnt5a. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32273724 | PubMed |
| 4 | 32286945 | Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A. | Curr Neurovasc Res | 2020 | https://conductscience.org/library/papers/32286945 | PubMed |
| 5 | 22409234 | The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases. | Nucleic Acid Ther | 2012 | https://conductscience.org/library/papers/22409234 | PubMed |
| 6 | 26328889 | Activation of PKA/CREB Signaling is Involved in BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells. | Cell Physiol Biochem | 2015 | https://conductscience.org/library/papers/26328889 | PubMed |
| 7 | 34854397 | miR-21 regulates osteogenic and adipogenic differentiation of BMSCs by targeting PTEN. | J Musculoskelet Neuronal Interact | 2021 | https://conductscience.org/library/papers/34854397 | PubMed |
| 8 | 33995677 | The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. | Theranostics | 2021 | https://conductscience.org/library/papers/33995677 | PubMed |
| 9 | 34370360 | MiR-26a-5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17. | Cell Biol Int | 2021 | https://conductscience.org/library/papers/34370360 | PubMed |
| 10 | 34532259 | Increased phosphorylated CREB1 protein correlates with poor prognosis in clear cell renal cell carcinoma. | Transl Androl Urol | 2021 | https://conductscience.org/library/papers/34532259 | PubMed |
| 11 | 33061604 | CREB1 Suppresses Transcription of microRNA-186 to Promote Growth, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells Through the KRT8/HIF-1α Axis. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33061604 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATHS | 470 | PubTator's text mining | https://conductscience.org/library/genes/470 | NCBI Gene |
| BGLAP | 632 | PubTator's text mining | https://conductscience.org/library/genes/632 | NCBI Gene |
| CREB1 | 1385 | PubTator's text mining | https://conductscience.org/library/genes/1385 | NCBI Gene |
| RUNX2 | 860 | PubTator's text mining | https://conductscience.org/library/genes/860 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37190841
GET https://conductscience.org/api/papers/v1/37190841/authors